Healthcare / Medical Care FacilitiesKuala Lumpur
$0.15
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 22%
FCF escenarios
weak_data · normalized FCF $1.3M · quality 46.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
37/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$48M
P/E
N/A
•EV/EBITDA
5.6x
↓ROE
4.7%
↑Gross Margin
49.9%
↑Debt/Equity
0.65
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+5.1%
FCF CAGR
-28.7%
FCF margin
2.9%
FCF / Net income
0.67x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $45.8M · net income $2.0M · FCF $1.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $45.8M | $45.8M | $44.2M | $43.0M | $39.5M |
| Net Income | $2.0M | $2.0M | $1.0M | $4.8M | $6.1M |
| EBITDA | $11.6M | $11.6M | $9.6M | $12.4M | $11.1M |
| EPS | — | — | 0.00 | 0.02 | 0.02 |
| Gross Margin | 49.9% | 49.9% | 51.2% | 49.4% | 50.9% |
| Operating Margin | 10.9% | 10.9% | 10.5% | 19.0% | 24.2% |
| Net Margin | 4.3% | 4.3% | 2.3% | 11.2% | 15.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.65 | 0.65 | 0.57 | 0.57 | 0.64 |
| Current Ratio | 4.02 | 4.02 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.3M | $1.3M | $-3.9M | $3.3M | $3.7M |
| Returns | |||||
| ROE | 4.7% | 4.7% | 2.2% | 16.4% | 22.9% |
| Valuation | |||||
| P/E | — | — | 89.71 | 40.54 | 34.88 |
| EV/EBITDA | 5.60 | 5.60 | 9.87 | 16.25 | 18.18 |
| P/B | 1.12 | 1.12 | 1.67 | 6.52 | 7.18 |
| Growth & Yield | |||||
| Revenue Growth | 3.7% | 3.7% | 2.9% | 8.9% | — |
| EPS Growth | — | — | -81.6% | -14.0% | — |
| Dividend Yield | 12.9% | 12.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-19.7%
Start / end P/E
n/dx → n/dx
EPS bridge
0.00 → n/d
Residual
-32.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.